Mark Simon - Oct 18, 2022 Form 4 Insider Report for Cabaletta Bio, Inc. (CABA)

Role
Director
Signature
/s/ Michael Gerard, Attorney-in-Fact
Stock symbol
CABA
Transactions as of
Oct 18, 2022
Transactions value $
$122,121
Form type
4
Date filed
10/18/2022, 09:50 PM
Previous filing
Jun 3, 2022
Next filing
Jun 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CABA Common Stock Purchase $115K +118K +650.35% $0.98* 136K Oct 18, 2022 Direct F1
transaction CABA Common Stock Purchase $6.83K +7K $0.98* 7K Oct 18, 2022 By Spouse F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased at prices ranging from $0.9315 to $0.99, inclusive. The reporting person has provided to the Issuer, and undertakes to provide any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased at prices ranging from $0.9375 to $0.9899, inclusive.